Published: Apr 03, 2024
Updated: Jan 23, 2026

Liver transplant rejection occurs when the body's immune system recognizes the newly transplanted liver as a foreign object and attempts to attack and destroy it. This phenomenon poses a significant threat to the success of liver transplantation, which is often a life-saving procedure for individuals with end-stage liver disease. Despite advancements in immunosuppressive therapies, rejection remains a potential complication that transplant recipients must be vigilant about. Understanding the signs and symptoms of liver transplant rejection is crucial for early detection and prompt intervention to preserve the health of the transplanted organ and the overall well-being of the recipient. In this article, we will explore the various manifestations of liver transplant rejection, enabling recipients and caregivers to recognize and respond to this critical issue effectively.
Liver transplant rejection occurs when the recipient's immune system recognizes the transplanted liver as foreign tissue and initiates an immune response to attack it. This reaction can occur any time after the transplant, but it's most common in the initial months following the procedure when the immune system is highly active. Rejection can be classified into three main types: hyperacute rejection, acute rejection, and chronic rejection. Each type varies in severity and onset. Hyperacute rejection is rare and typically occurs within the first 24 hours after transplantation. Acute rejection is more common and can manifest within the first few weeks to months post-transplant. Chronic rejection develops gradually over months to years and is characterized by progressive deterioration of the transplanted liver.
Liver transplantation is a life-saving procedure for individuals with end-stage liver disease, offering hope for improved health and quality of life. However, the risk of rejection remains a significant concern, emphasizing the importance of early detection and intervention through vigilant monitoring of symptoms.

Tanya Bose is a medical content specialist with a strong medical background. She has completed her Bachelor's and Master’s in Biotechnology from Amity University. With a deep understanding of biomedical sciences and research, she develops authoritative and patient-focused medical content covering treatments, surgical procedures, and healthcare innovations. Her writing emphasizes accuracy, clarity, and evidence-based information to help readers better understand complex medical topics. She is dedicated to improving patient awareness and supporting informed healthcare decisions by delivering trustworthy medical insights in a clear and accessible format.

Dr Vihan Gautam is a rehab specialist and healthcare management professional with experience in neuro-rehabilitation, AI-driven care models, and strategic healthcare operations. He has worked across clinical and business roles, contributing to physiotherapy knowledge systems, international rehab programs, and multidisciplinary care initiatives focused on improving patient outcomes.





Delhi, India

Istanbul, Turkey

Istanbul, Turkey

Istanbul, Turkey